BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

258 related articles for article (PubMed ID: 28609019)

  • 1. Synthesis, biological evaluation, and molecular docking studies of novel 3-aryl-5-(alkyl-thio)-1H-1,2,4-triazoles derivatives targeting Mycobacterium tuberculosis.
    Rode ND; Sonawane AD; Nawale L; Khedkar VM; Joshi RA; Likhite AP; Sarkar D; Joshi RR
    Chem Biol Drug Des; 2017 Dec; 90(6):1206-1214. PubMed ID: 28609019
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synthesis and bioactivity of novel triazole incorporated benzothiazinone derivatives as antitubercular and antioxidant agent.
    Shaikh MH; Subhedar DD; Arkile M; Khedkar VM; Jadhav N; Sarkar D; Shingate BB
    Bioorg Med Chem Lett; 2016 Jan; 26(2):561-569. PubMed ID: 26642768
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synthesis, biological evaluation and molecular docking study of some novel indole and pyridine based 1,3,4-oxadiazole derivatives as potential antitubercular agents.
    Desai NC; Somani H; Trivedi A; Bhatt K; Nawale L; Khedkar VM; Jha PC; Sarkar D
    Bioorg Med Chem Lett; 2016 Apr; 26(7):1776-83. PubMed ID: 26920799
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Novel Benzylidenehydrazide-1,2,3-Triazole Conjugates as Antitubercular Agents: Synthesis and Molecular Docking.
    Shaikh MH; Subhedar DD; Nawale L; Sarkar D; Khan FAK; Sangshetti JN; Shingate BB
    Mini Rev Med Chem; 2019; 19(14):1178-1194. PubMed ID: 30019644
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthesis and biological evaluation of novel 1,2,3-triazole derivatives as anti-tubercular agents.
    Aziz Ali A; Gogoi D; Chaliha AK; Buragohain AK; Trivedi P; Saikia PJ; Gehlot PS; Kumar A; Chaturvedi V; Sarma D
    Bioorg Med Chem Lett; 2017 Aug; 27(16):3698-3703. PubMed ID: 28712709
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Design and synthesis of 9H-fluorenone based 1,2,3-triazole analogues as Mycobacterium tuberculosis InhA inhibitors.
    Suresh A; Srinivasarao S; Agnieszka N; Ewa AK; Alvala M; Lherbet C; Chandra Sekhar KVG
    Chem Biol Drug Des; 2018 Jun; 91(6):1078-1086. PubMed ID: 29063733
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Imidazole and 1,2,4-Triazole-based Derivatives Gifted with Antitubercular Activity: Cytotoxicity and Computational Assessment.
    Zampieri D; Cateni F; Moneghini M; Zacchigna M; Laurini E; Marson D; De Logu A; Sanna A; Mamolo MG
    Curr Top Med Chem; 2019; 19(8):620-632. PubMed ID: 30827247
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synthesis and biological evaluation of 1H-pyrrolo[2,3-d]pyrimidine-1,2,3-triazole derivatives as novel anti-tubercular agents.
    Shiva Raju K; AnkiReddy S; Sabitha G; Siva Krishna V; Sriram D; Bharathi Reddy K; Rao Sagurthi S
    Bioorg Med Chem Lett; 2019 Jan; 29(2):284-290. PubMed ID: 30497913
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Design, synthesis and biological evaluation of novel 1,2,3-triazole analogues of Imidazo-[1,2-a]-pyridine-3-carboxamide against Mycobacterium tuberculosis.
    Nandikolla A; Srinivasarao S; Khetmalis YM; Kumar BK; Murugesan S; Shetye G; Ma R; Franzblau SG; Sekhar KVGC
    Toxicol In Vitro; 2021 Aug; 74():105137. PubMed ID: 33684466
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Quinolidene-rhodanine conjugates: Facile synthesis and biological evaluation.
    Subhedar DD; Shaikh MH; Shingate BB; Nawale L; Sarkar D; Khedkar VM; Kalam Khan FA; Sangshetti JN
    Eur J Med Chem; 2017 Jan; 125():385-399. PubMed ID: 27688192
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rational design and synthesis of novel dibenzo[b,d]furan-1,2,3-triazole conjugates as potent inhibitors of Mycobacterium tuberculosis.
    Yempala T; Sridevi JP; Yogeeswari P; Sriram D; Kantevari S
    Eur J Med Chem; 2014 Jan; 71():160-7. PubMed ID: 24292337
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Quinolidene based monocarbonyl curcumin analogues as promising antimycobacterial agents: Synthesis and molecular docking study.
    Subhedar DD; Shaikh MH; Nawale L; Sarkar D; Khedkar VM; Shingate BB
    Bioorg Med Chem Lett; 2017 Feb; 27(4):922-928. PubMed ID: 28110868
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A convenient synthesis and screening of benzosuberone bearing 1,2,3-triazoles against Mycobacterium tuberculosis.
    Sajja Y; Vanguru S; Jilla L; Vulupala HR; Bantu R; Yogeswari P; Sriram D; Nagarapu L
    Bioorg Med Chem Lett; 2016 Sep; 26(17):4292-5. PubMed ID: 27476139
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synthesis and biological evaluation of 1,2,4-triazole-3-thione and 1,3,4-oxadiazole-2-thione as antimycobacterial agents.
    Sonawane AD; Rode ND; Nawale L; Joshi RR; Joshi RA; Likhite AP; Sarkar D
    Chem Biol Drug Des; 2017 Aug; 90(2):200-209. PubMed ID: 28083914
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Discovery of 1,2,3-triazole based quinoxaline-1,4-di-N-oxide derivatives as potential anti-tubercular agents.
    Srinivasarao S; Nandikolla A; Suresh A; Ewa AK; Głogowska A; Ghosh B; Kumar BK; Murugesan S; Pulya S; Aggarwal H; Sekhar KVGC
    Bioorg Chem; 2020 Jul; 100():103955. PubMed ID: 32464405
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Design and synthesis of 11α-substituted bile acid derivatives as potential anti-tuberculosis agents.
    Pore VS; Divse JM; Charolkar CR; Nawale LU; Khedkar VM; Sarkar D
    Bioorg Med Chem Lett; 2015 Oct; 25(19):4185-90. PubMed ID: 26299346
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Design and synthesis of 1H-1,2,3-triazoles derived from econazole as antitubercular agents.
    Kim S; Cho SN; Oh T; Kim P
    Bioorg Med Chem Lett; 2012 Nov; 22(22):6844-7. PubMed ID: 23058885
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Design, Synthesis, and in vitro antitubercular activity of 1,2,3-triazolyl-dihydroquinoline derivatives.
    Banu S; Bollu R; Nagarapu L; Nanubolu JB; Yogeswari P; Sriram D; Gunda SK; Vardhan D
    Chem Biol Drug Des; 2018 Jul; 92(1):1315-1323. PubMed ID: 29624868
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synthesis and antitubercular activity of new 1,3,4-oxadiazoles bearing pyridyl and thiazolyl scaffolds.
    Dhumal ST; Deshmukh AR; Bhosle MR; Khedkar VM; Nawale LU; Sarkar D; Mane RA
    Bioorg Med Chem Lett; 2016 Aug; 26(15):3646-51. PubMed ID: 27301367
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 1H-1,2,3-Triazole tethered isatin-moxifloxacin: Design, synthesis and in vitro anti-mycobacterial evaluation.
    Jiang Y; Qian A; Li Y
    Arch Pharm (Weinheim); 2019 Jul; 352(7):e1900040. PubMed ID: 31106443
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.